2025-03-12 11:44:38
Latest Post
W S Industries India Ltd's subsidiary to acquire 54.89 acres land for Rs. 46.66 crores
IKS Health wins Top Honors in 2025 Black Book Survey in New AI-Driven RCM Category
Mipco Seamless Rings Gujarat Ltd approves shifting of registered office
Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO
REC Limited inaugurates REC Experience Center
Stock Report
AstraZeneca Pharma India Ltd posts Rs. 27.98 crores profit in Q4 FY2022
Posted On : 2022-05-27 13:00:04( TIMEZONE : IST )
AstraZeneca Pharma India Limited has reported Standalone financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 235.6472 crores during the period ended March 31, 2022 as compared to Rs. 205.8578 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. 27.9833 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 11.4192 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. 11.19 for the period ended March 31, 2022 as compared to Rs. 4.57 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹235.6472 crs | ₹205.8578 crs |  14.47% |
| Net Profit | ₹27.9833 crs | ₹11.4192 crs | 145.05% |
| EPS | ₹11.19 | ₹4.57 | 144.86% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs.235.6472 crores during the period ended March 31, 2022 as compared to Rs.212.8097 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.27.9833 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.27.2789 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.11.19 for the period ended March 31, 2022 as compared to Rs.10.91 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹235.6472 crs | ₹212.8097 crs | 10.73% |
| Net Profit | ₹27.9833 crs | ₹27.2789 crs | 2.58% |
| EPS | ₹11.19 | ₹10.91 | 2.57% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.820.3577 crores during the Financial Year ended March 31, 2022 as compared to Rs.826.4052 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.61.5928 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.93.3035 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.24.64 for the Financial Year ended March 31, 2022 as compared to Rs.37.32 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹820.3577 crs | ₹826.4052 crs |  -0.73% |
| Net Profit | ₹61.5928 crs | ₹93.3035 crs | -33.99% |
| EPS | ₹24.64 | ₹37.32 | -33.98% |
Shares of AstraZeneca Pharma India Limited was last trading in BSE at Rs. 2649.50 as compared to the previous close of Rs. 2627.80. The total number of shares traded during the day was 199 in over 140 trades.
The stock hit an intraday high of Rs. 2669.05 and intraday low of 2569.50. The net turnover during the day was Rs. 519875.00.
